对 Isorhamnetin 的机制见解:针对 MAPK 和 NF-κB 途径来缓解 LPS 诱导的炎症
Abdelrahim Alqudah1, Muna Barakat2, Lujain F Alzaghari2
1Department of Clinical Pharmacy and Pharmacy Practice, Faculty of Pharmaceutical Sciences, The Hashemite University, Zarqa 13133, Jordan.
Current molecular pharmacology
|April 29, 2025
概括
伊索哈姆尼丁 (ISO) 通过降低关键炎症媒介和细胞因子,有效降低炎症. 这种天然化合物针对关键的炎症通路,显示治疗炎症疾病的潜力.
科学领域:
- 生物化学 生物化学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 慢性炎症可能导致粘膜损伤和疼痛和发烧等症状.
- 研究天然化合物的抗炎性质对于开发新疗法至关重要.
研究的目的:
- 为了评估异胺素 (ISO) 的抗炎作用.
- 探索ISO作为治疗炎症病的药剂的潜力.
主要方法:
- 在体外研究中使用脂聚糖 (LPS) 刺激的RAW 264.7巨细胞.
- 对促炎性细胞因子 (IL-1β,IL-6,TNF-α) 和介导体 (NO,PGE2) 的量化.
- 对iNOS和COX-2的mRNA水平的分析,以及对MAPK和NF-κB信号通路的调查.
主要成果:
- ISO显著降低了氧化 (NO) 和前列腺素E2 (PGE2) 的水平.
- ISO剂量依赖性降低了促炎性细胞因子合成.
- ISO抑制了MAPK通路的酸化,并降低了NF-κB通路中的IκB-α,降低了iNOS和COX-2mRNA水平.
结论:
- 伊索哈姆尼丁显示出显著的抗炎性质.
- 通过抑制关键的炎症信号通路 (MAPK和NF-κB) 来起作用.
- 国际标准组织 (ISO) 提出了一种有前途的治疗候选药物,用于治疗炎症性疾病.
更多相关视频
相关概念视频
NF-κB-dependent Signaling Pathway
7.2K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.2K
MAPK Signaling Cascades
4.9K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
4.9K
The JAK-STAT Signaling Pathway
8.4K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.4K
Regulation of the Unfolded Protein Response
2.3K
Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.3K


